Consistently, Ivermectin treatment repressed a lung cancer WNT-TCF signature that included the direct targetsAXIN2,LEF1, SOX4, andCYCLIND1 (asASCL2 andLGR5 are not expressed in these cells) and enhancedp21 levels (Supplementary Fig S5). Here, LEF1 is linked to lung cancer.